NCT06619353

RCVR (Residual CardioVascular Risk) Prospective Study

Residual CardioVascular Risk (RCVR) After Percutaneous Coronary Intervention: A Prospective Study

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 500 (actual)
• Sponsor: CHA University · Academic / Other
• Sex: All
• Age: 20 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

The goal of this observational study is to evaluate whether residual cardiovascular risk assessed at 1 month after percutaneous coronary intervention (PCI) is associated with long-term clinical outcomes in adult patients with coronary artery disease who are free from major adverse clinical events at 1 month after PCI. The main questions it aims to answer are: * Does residual cardiovascular risk at 1 month after PCI predict long-term net adverse clinical events? * Which components of residual cardiovascular risk are associated with subsequent adverse clinical outcomes? Participants will: * Undergo comprehensive laboratory testing at 1 month after PCI and annually thereafter. * Undergo artificial intelligence-based quantitative coronary angiographic analysis using DICOM datasets after PCI. * Be followed annually for up to 3 years after the 1-month assessment to evaluate clinical outcomes.

Conditions

• Coronary Artery Disease

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Blood Sample	Patients' blood samples are tested at 1 month, and then annually for 3 years post-intervention to assess residual thrombotic, metabolic, and inflammatory risk.
OTHER	DICOM Dataset	Patients' DICOM dataset is evaluated using artificial intelligence-based quantitative coronary analysis to assess a procedural risk.

Timeline

• Start date: 2024-06-17
• Primary completion: 2029-02-01
• Completion: 2029-02-01
• First posted: 2024-10-01
• Last updated: 2026-02-18

Locations

1 site across 1 country: South Korea